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Abstract  
Body lice transport B. recurrentis from man to man and humans are the only host. The presence of 
lice in Italy and an increasing number of cases in migrants can contribute to the onset of 
autochthonous cases. In this paper, we report a new case of Louse-borne Relapsing Fever (LBRF) 
diagnosed among migrants in Sicily exactly one year after the first case was recorded. We  
reviewed all cases reported in Europe from February 2016 until now. Our study identified two new 
cases of LBRF in migrants arrived in Europe: one who came from Somalia and one from Mali. 
Here we report data on a new case in Sicily. The number of migrants and refugees to transit in 
Sicily has increased, and this has led to the introduction of infectious diseases. Therefore, in our 
opinion it is essential to upgrade control of the sanitation conditions of migrants. 
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Introduction 
Louse-borne relapsing fever (LBRF) caused by 
Borrelia recurrentis occurs in epidemics amid 
poor living conditions, famine and war in the 
developing world [1].  
LBRF has been restricted to East Africa for 
many decades with most cases reported from 
Ethiopia where significant disease remains 
because poverty, lack of hygiene and crowded 
living conditions are responsible for large 
outbreaks [2-3]. 
In the context of an ongoing influx of refugees 
from East Africa into Europe over the last year, 
four cases of louse-borne relapsing fever (LBRF) 
caused by B. recurrentis were reported between 
July and December 2015 in migrants from 
Somalia to refugee camps in Sicily, Italy [4-5]. In 
the same period a total of 33 new cases of LBRF 
were reported between July and December 2015 
in migrants arrived in Europe. In detail, 11 had 
been described in Italy, one in Switzerland, one in 
Belgium, two in Finland, two in the Netherlands 
and 16 in Germany [4-9]. 
In addition, two new sporadic cases of LBRF 
have been reported in Europe from February 2016 
until now. 
The aim of this paper was to report a new case 
of LBRF in a migrant from Somalia to refugee 
camps in Sicily in July 2016, and to review all 
cases reported in Europe in the same period. 
Case report 
The patient was a 16-year-old girl from Somalia 
who arrived in Palermo, Italy, on July 12, 2016. 
Fever, artromyalgia, severe dehydration and 
mental confusion developed 4 days after her 
arrival, and she was admitted to the Paolo 
Giaccone University Hospital in Palermo. She had 
severe thrombocytopenia (69,000 platelets/μL); 
mild anemia (hemoglobin level 10 g/dL); 
increased levels of aminotransferases (aspartate 
aminotransferase 47 U/L), lactate dehydrogenase 
(872 U/L [reference range 240 U/L−480 U/L]), 
alkaline phosphatase (219 U/L [range 0-187 
U/L]), d-dimer (7,366 ng/mL [reference range 10 
ng/mL–250 ng/mL]), C-reactive protein (285.7 
mg/L [reference range <5 mg/L]). 
In order to rule out malaria, we immediately 
performed thick and thin blood films and antigen 
tests with negative results. However, Giemsa-
stained thick and thin films revealed filamentous 
structure attributed to spirochetes, with 
microbiological features attributable to Borrelia 
species (Figure 1). 
DNA was extracted from blood in EDTA and 
used for molecular identification and 
characterization of the etiologic agent of LBRF. 
We used a species-specific real-time PCR 
for B.recurrentis and B.duttonii, which targeted an 
internal region of the recN gene. Multispacer 
sequence typing of the 16S rRNA gene was used 
for bacterial identification and genotyping [10-
11]. The blood sample was positive 
for B.recurrentis by real-time PCR. Multispacer 
sequences showed 100% identity with sequences 
of B.recurrentis reference strain A1 (GenBank 
accession no. CP000993).  
The patient recovered after treatment with 
doxycycline (100 mg/d) and ceftriaxone (2 g/d) 
for 10 days. We conducted a PubMed search and 
found four articles reporting five cases of LBRF 
in Europe from February 2016 until now.  
One case was reported in Germany and 
involved Somalis and one in Italy involved a 
patient from Mali [12,13].  Data concerning  
clinical characteristics, diagnostic approaches and 
therapy are reported in Table 1. 
All the cases had analogous clinical symptoms, 
and following therapy the outcome was good. 
Moreover, in the three cases the diagnosis was 
based on visible spirochetes on Giemsa films and 
confirmed by PCR.  
Discussion 
For B.recurrentis and B.duttoni, a natural host 
other than humans has not been identified, and the 
vector is also the reservoir. Furthermore, humans’ 
role is amplification of infected vectors and can be 
considered as the reservoir for infection. Kisinza 
et al. in the Dodoma region of Tanzania found 5% 
of febrile children had positive blood
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slides for Borrelia spp. Others studying non-
febrile persons have reported that 3% of them are 
spirochetemic by blood film examination [14]. 
The ongoing “humanitarian crisis” with 
thousands of refugees and migrants arriving daily 
in Sicily after perilous journeys in crowded and 
poor hygienic conditions is a definite risk factor 
for possible explosive outbreaks of arthropod-
borne diseases [15,19-21].  
In all the cases reported, LBRF was not 
suspected because its clinical presentation is 
similar to other diseases such as dengue, malaria 
and secondary hemophagocytic 
lymphohistiocytosis [16,17, 22,23]. 
However, in order to avoid that spirochetes in 
blood films go unnoticed, the microbiologist 
should be alerted to the risk of LBRF infection in 
patients from endemic areas [9].  
In addition, PCR targeting 16S rRNA was used 
to confirm the presence of spirochetes and to 
identify the species level, because it is 
problematic to discriminate between LBRF and 
tick-borne relapsing fever by microscopic analysis 
alone. Furthermore, discrimination between the 
two diseases is significant for treatment: for 
LBRF a single dosage of 500 mg tetracycline is 
the conventional cure, while tick-borne relapsing 
fever needs to be treated for at least 7 days [18].  
Based on this evidence, the presence of lice in 
Italy associated with the increasing number of 
cases as a consequence of the new migration wave 
from endemic areas could be a source of infected 
vectors. Consequently, the occurrence of cases of 
autochthonous disease can be supposed, and this 
highlights the need for clinicians to consider 
LBRF when treating a patient from Eastern Africa 
with fever. 
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Figure 1. Giemsa-stained showing one spirochete. 
 
 
 
Table 1. Characteristics of patients with LBRF, method of diagnosis and treatment. 
 
Reference Age/Sex Country of 
origin 
Symptom Methods of 
diagnosis 
Therapy 
Grecchi C et 
al. 2017 
20/M Mali 
- Fever 
- Headache 
- abdominal 
pain 
- Microscopy 
- NAAT 
 
Doxycycline 
and 
ceftriaxone 
von Both U 
and Alberer 
M. 2016 
16/M Somalia 
- Fever 
- Headache 
- Asthenia 
- Microscopy 
- NAAT 
 
Doxycycline 
This case 16/F Somalia 
- Fever 
- Headache 
- Artromyalgia 
- Microscopy 
- NAAT 
 
Doxycycline 
and 
ceftriaxone 
M= male, F= female, NAAT= nucleic acid amplification techniques 
 
